Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen.
about
The Yersinia Yop virulon: LcrV is required for extrusion of the translocators YopB and YopD.The virulence plasmid of Yersinia, an antihost genomeMutated and bacteriophage T4 nanoparticle arrayed F1-V immunogens from Yersinia pestis as next generation plague vaccinesImmune defense against pneumonic plagueAmino acid and structural variability of Yersinia pestis LcrV protein.The smpB-ssrA mutant of Yersinia pestis functions as a live attenuated vaccine to protect mice against pulmonary plague infectionThe Yersinia deadly kiss.Analysis of the Yersinia pestis V protein for the presence of linear antibody epitopesPolymorphisms in the Pseudomonas aeruginosa type III secretion protein, PcrV - implications for anti-PcrV immunotherapySilencing and reactivation of urease in Yersinia pestis is determined by one G residue at a specific position in the ureD gene.A hypervariable N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence.Evaluation of Psn, HmuR and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challengeHSP70 domain II of Mycobacterium tuberculosis modulates immune response and protective potential of F1 and LcrV antigens of Yersinia pestis in a mouse model.Development of a vaccinia virus based reservoir-targeted vaccine against Yersinia pestisAdvanced Development of the rF1V and rBV A/B Vaccines: Progress and Challenges.Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization.Intraspecific diversity of Yersinia pestis.Development of in vitro correlate assays of immunity to infection with Yersinia pestis.Polymorphisms in the lcrV gene of Yersinia enterocolitica and their effect on plague protective immunity.Amino acid substitutions in LcrV at putative sites of interaction with Toll-like receptor 2 do not affect the virulence of Yersinia pestisYersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppressionAcquisition of maternal antibodies both from the placenta and by lactation protects mouse offspring from Yersinia pestis challenge.Current challenges in the development of vaccines for pneumonic plague.Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts.Oral vaccination against bubonic plague using a live avirulent Yersinia pseudotuberculosis strain.Vaccination of mice with a Yop translocon complex elicits antibodies that are protective against infection with F1- Yersinia pestisClinical and pathologic features of cynomolgus macaques (Macaca fascicularis) infected with aerosolized Yersinia pestis.Immunogenicity and safety of subunit plague vaccine: A randomized phase 2a clinical trial.Oral vaccination with LcrV from Yersinia pestis KIM delivered by live attenuated Salmonella enterica serovar Typhimurium elicits a protective immune response against challenge with Yersinia pseudotuberculosis and Yersinia enterocolitica.Immunomodulatory Yersinia outer proteins (Yops)-useful tools for bacteria and humans alike.Rational live oral carrier vaccine design by mutating virulence-associated genes of Yersinia enterocoliticaDNA sequencing and analysis of the low-Ca2+-response plasmid pCD1 of Yersinia pestis KIM5.Purification and characterization of Yersinia enterocolitica and Yersinia pestis LcrV-cholera toxin A(2)/B chimeras.Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection.Mechanisms of major histocompatibility complex class II-restricted processing and presentation of the V antigen of Yersinia pestis.Yersinia pestis V protein epitopes recognized by CD4 T cells.
P2860
Q24520677-BBC518D2-6B8E-4FDE-A7D5-9A3D0D684343Q28290675-00BE3CB7-7002-489C-BFDB-C3C808F49CBFQ28678943-3E2695CC-D263-4C57-B01C-9A20A01413D4Q33584403-7D771245-7677-47D0-958F-52606B50B5CEQ33636983-DE4B99B8-67FE-4C0D-B00F-C629B7CB36EAQ33675834-5B616AA4-6A01-4368-85BB-A67A28B794A0Q33738622-82F6334D-DD8A-49CF-8BD1-C9432F01B17EQ33750146-5DC57922-71EA-4F3D-97BC-EEC558C8FEF1Q33812082-B5706377-7F52-46E2-8EDC-8C453BC24735Q34005545-380BA43B-50D5-4D2B-867B-646DB84B7F1CQ34115870-D8FF00F7-29B0-4F47-85E1-D73E07862F64Q34457319-88B0116A-039C-4E22-93FD-4949AF09FA47Q34633478-D034C89B-C837-43B4-AEB6-D6E738C654DDQ35090599-9FE98C6F-CCD9-46A8-8C73-50818951F53EQ35418294-D768567A-8F11-45E7-B7FC-F01824146573Q35557573-31CE341B-15D3-4AC1-B885-7EB5D13D84C8Q35745842-15D13633-7765-4226-93CF-359E74B1BDA9Q35783560-415DAB34-E288-45BF-AA86-61BD54F36E30Q35867550-9E17E425-B3A9-4BD8-8CCE-430BDE45C126Q36315395-C18A41DF-9304-4AF6-8CD9-7B3496AAC366Q36371199-1C32D448-84D9-4AED-8C2B-58398D45C326Q36378660-2163378C-7407-43E5-ACC8-0C6393A7EB81Q36628038-52900AC2-6174-457B-92F7-4F7EE4033EEBQ36804213-932F7715-4D02-499F-B767-F3159E18949BQ36804222-B8CBA889-9AFC-4E3F-ADC9-E82CDAD05360Q36950063-CC7201D6-C3D5-4FA7-B5BC-3CEDC8CF9FB4Q37243854-BCF7839F-F8E8-44E2-9B76-89A36AD58BAAQ37264991-20649FF6-2F34-48D6-A2B4-C61E6AB7AF32Q37362381-2A6E4D8D-F8E1-494B-A414-92E3B839027FQ39180064-09B14E8F-7ED7-4879-9012-D7990642ABD6Q39512451-1AB66C1A-3C32-4ED8-A734-DBF6D7A1EFCCQ39573090-428A0578-3936-43C2-8008-542E2AB2A15BQ41434206-CBB310AD-0503-47ED-9540-C988E60CBC09Q41451306-976E8D1B-FC8B-4DA3-939A-9B0EF1DD18F3Q41452700-9A87AC16-D304-4BC0-A04A-6DFF083A8A06Q41459022-7931091A-3BAD-4715-B397-ECEADE3C2F57
P2860
Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen.
description
1997 nî lūn-bûn
@nan
1997 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Passive immunity to infection ...... on polymorphism of V antigen.
@ast
Passive immunity to infection ...... on polymorphism of V antigen.
@en
type
label
Passive immunity to infection ...... on polymorphism of V antigen.
@ast
Passive immunity to infection ...... on polymorphism of V antigen.
@en
prefLabel
Passive immunity to infection ...... on polymorphism of V antigen.
@ast
Passive immunity to infection ...... on polymorphism of V antigen.
@en
P2093
P2860
P1476
Passive immunity to infection ...... on polymorphism of V antigen.
@en
P2093
Heesemann J
Leitritz L
Roggenkamp A
P2860
P304
P407
P577
1997-02-01T00:00:00Z